tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Chris Schott, 69 are a HOLD (26.64%), 180 are a BUY (69.5%), 10 are a SELL (3.86%).
Analyst Chris Schott, currently employed at JPMORGAN, carries an average stock price target met ratio of 55.1% that have a potential upside of 29.63% achieved within 394 days.
Chris Schott’s has documented 526 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AMRX, Amneal Pharmaceuticals, Common Stock at 26-Aug-2026.
Analyst best performing recommendations are on EQRX (EQRX).
The best stock recommendation documented was for EQRX (EQRX) at 8/16/2022. The price target of $5.5 was fulfilled within 3 days with a profit of $0.67 (13.87%) receiving and performance score of 46.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2026
$315
$57.88 (22.51%)
$265
Buy Since 12-Sep-2025
$303
$45.88 (17.84%)
$298
25 days ago
(20-Aug-2026)
2/8 (25%)
$41.17 (15.72%)
35
Buy Since 08-Dec-2021
$300
$42.88 (16.68%)
$295
28 days ago
(17-Aug-2026)
9/11 (81.82%)
$49.67 (19.84%)
469
Buy Since 23-Jan-2023
$260
$2.88 (1.12%)
$235
1 months 4 days ago
(10-Aug-2026)
9/9 (100%)
$12.03 (4.85%)
127
Buy Since 06-Feb-2020
$288
$30.88 (12.01%)
$261
1 months 10 days ago
(04-Aug-2026)
36/37 (97.3%)
$44.2 (18.13%)
434
Which stock is Chris Schott most bullish on?
Which stock is Chris Schott most reserved on?
What Year was the first public recommendation made by Chris Schott?
